These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 20666

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
    Beretta-Piccoli C, Weidmann P, de Châtel R, Hirsch D, Reubi FC.
    Schweiz Med Wochenschr; 1977 Jan 29; 107(4):104-15. PubMed ID: 834983
    [Abstract] [Full Text] [Related]

  • 3. Beta-adrenergic blockade in diuretic-treated patients with essential hypertension.
    Bravo EL, Tarazi RC, Dustan HP.
    N Engl J Med; 1975 Jan 09; 292(2):66-70. PubMed ID: 234005
    [Abstract] [Full Text] [Related]

  • 4. [Exchangeable sodium, total-body potassium, plasma volume, and hypotensive effect of various diuretics in patients with essential hypertension and low plasma renin level (author's transl)].
    Distler A, Keim HJ, Philipp T, Philippi A, Walter U, Werner E.
    Dtsch Med Wochenschr; 1974 Apr 26; 99(17):864-9. PubMed ID: 4834874
    [No Abstract] [Full Text] [Related]

  • 5. Volume-pressure relationships during development of mineralocorticoid hypertension in man.
    Wenting GH, Man in 't Veld AJ, Verhoeven RP, Derkx FH, Schalekamp DH.
    Circ Res; 1977 May 26; 40(5 Suppl 1):I163-70. PubMed ID: 858175
    [Abstract] [Full Text] [Related]

  • 6. Circulatory volume in essential hypertension. Relationships with age, blood pressure, exchangeable sodium, renin, aldosterone and catecholamines.
    Beretta-Piccoli C, Weidmann P.
    Miner Electrolyte Metab; 1984 May 26; 10(5):292-300. PubMed ID: 6387428
    [Abstract] [Full Text] [Related]

  • 7. [Relations between hypotensive effect and modifications of volemia and plasma renin activity in patients with essential hypertension treated using spironolactone].
    Pessina AC, Corgnati A, Palù CD.
    Minerva Med; 1977 Feb 18; 68(8):509-14. PubMed ID: 846681
    [Abstract] [Full Text] [Related]

  • 8. [Role of renin profile and age in the choice of the therapeutic approach of arterial hypertension (author's transl)].
    Glorioso N, Madeddu P, Dessì Fulgheri P, Sanna G, Fiori C, Dettori S, Cocco F, Rappelli A.
    G Ital Cardiol; 1981 Feb 18; 11(12):2117-25. PubMed ID: 6125451
    [Abstract] [Full Text] [Related]

  • 9. [Drug combinations in the treatment of primary arterial hypertension].
    Angelino PF.
    Minerva Med; 1975 Feb 21; 66(13):602-11. PubMed ID: 1113910
    [Abstract] [Full Text] [Related]

  • 10. [Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension].
    Naudzhunas A, Bagdonas G, Yankauskene L, Kazanavichus G.
    Ter Arkh; 2006 Feb 21; 78(2):61-4. PubMed ID: 16613101
    [Abstract] [Full Text] [Related]

  • 11. [Behavior of cardiac output, plasma volume, plasma renin activity and aldosterone secretion in patients with essential hypertension treated with beta-blocking agents and diuretics].
    Salerno L, Licata G, Sparacino V, Custro N, Indovina I.
    Clin Ter; 1979 Aug 15; 90(3):223-32. PubMed ID: 45260
    [No Abstract] [Full Text] [Related]

  • 12. [Differential therapeutic principles in the drug therapy of high blood pressure].
    Rahn KH.
    Internist (Berl); 1974 Mar 15; 15(3):157-64. PubMed ID: 4151964
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.
    Kreeft JH, Larochelle P, Ogilvie RI.
    Can Med Assoc J; 1983 Jan 01; 128(1):31-4. PubMed ID: 6336600
    [Abstract] [Full Text] [Related]

  • 14. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S, Bernheim J, Podjarny E.
    Isr Med Assoc J; 2002 Jan 01; 4(1):17-20. PubMed ID: 11802302
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of some beta-blocking drugs on plasma renin activity, platelet adhesiveness and dilute blood clot lysis time in patients with essential arterial hypertension.
    Vlaicu R, Uza G, Mărcuş C, Voinescu I.
    Med Interne; 1980 Jan 01; 18(3):247-51. PubMed ID: 6106281
    [Abstract] [Full Text] [Related]

  • 17. [The role of renin after betablocking diuretic and vasodilator treatment in essential hypertension (author's transl)].
    Lombardo M, Fusco M, Valente D.
    G Ital Cardiol; 1979 Jan 01; 9(12):1363-70. PubMed ID: 45015
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ, Schalekamp MA.
    Postgrad Med J; 1983 Jan 01; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.